Integra Lifesciences Holdings Corp
NASDAQ:IART
Integra Lifesciences Holdings Corp
Cash from Operating Activities
Integra Lifesciences Holdings Corp
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
Cash from Operating Activities
$140m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
10%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Integra Lifesciences Holdings Corp's Cash from Operating Activities?
Cash from Operating Activities
140m
USD
Based on the financial report for Dec 31, 2023, Integra Lifesciences Holdings Corp's Cash from Operating Activities amounts to 140m USD.
What is Integra Lifesciences Holdings Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
10%
Over the last year, the Cash from Operating Activities growth was -47%. The average annual Cash from Operating Activities growth rates for Integra Lifesciences Holdings Corp have been -12% over the past three years , -7% over the past five years , and 10% over the past ten years .